Treatment for lung cancer has changed significantly with immunotherapy, an expert said during the CURE® Educated Patient® ...

Are cancer vaccines the new frontier in oncology? Experts and patients weigh in from the front lines. Vaccines are making ...

Having my metastatic breast cancer experience turned into a piece of art was such a meaningful opportunity. The invitation ...

Patients with chronic lymphocytic leukemia or small lymphocytic lymphoma tended to be less likely to stay on treatment and experience fewer heart toxicities. Both Calquence (acalabrutinib) and ...

Leaning on spiritual belief may strengthen patients' life purposes, but for many, it's common to temporarily loosen their ...

Again, it is my turn to visit the solitude of the chemo room to treat my non-Hodgkin lymphoma. I entered the land of many red ...

Approximately half of the patients with MDS who responded to treatment Rytelo went a year without needing a blood transfusion ...

A reduced dosing schedule of Tecvayli (teclistamab) continued to slow the progression of relapsed or refractory multiple ...

Experiencing losing a friend to cancer in the cancer community is never easy, but it’s OK to allow your heart to break.

Patients who received systemic therapy at the end of life did not have longer overall survival averages than those who did ...

The Food and Drug Administration approved Keytruda plus chemotherapy, followed by single-agent Keytruda for primary advanced ...

Increased awareness and support may be one of the many ways to help decrease the impact of disparities in multiple myeloma.